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1, INTRODUCTION 
Slow reacting substance of anaphylaxis (SRS-A) 
produced by basophils or mast cells is a broncho- 
constrictive agent believed to be an important med- 
iator of allergic asthma in man. SRS-A has been 
named leukotriene (LT) C4 and D4 and was formed 
by 5lipoxygenase from arachidonic acid which also 
synthesizes LTA4 and LTB4 [ 11. LTB4, C4 and D4 
may have important roles in the inflammatory 
response [2,3]. Therefore, the discovery of specific 
inhibitors for 5lipoxygenase could lead to the de- 
velopment of new anti-asthmatic and anti-inflam- 
matory drugs. 
(Osaka): authentic 5-hydroxyeicosatetraenoic acid 
(HETE) and prostaglandin standards, Ono Pharma- 
ceutical Co. (Osaka); thin-layer silica gel plates 
(6OF254; layer thickness 0.25 mm), Merck Co. 
(Darmstadt). 
2.2. Cell culture 
The first leukotriene formed in the %lipoxygen- 
ase pathway is LTA4, which is a relatively unstable 
intermediate with an epoxide unit of all the follow- 
ing leukotrienes. We found that 5,6-methanoleuko- 
triene A4, which is chemically synthesized and a 
stable analogue of LTA4 [4], selectively inhibited 
5-lipoxygenase in comparison with fatty acid 
cyclooxygenase (EC 1.14.99.1). 
For assaying both lipoxygenase and cyclooxy- 
genase activities simultaneously, we developed a 
unique in vitro experimental system using a cloned 
mastocytoma P-8 15,2-E-6 cells. 
Mastocytoma P-8 15 cells, originally established 
as a transformed mast cell line [5], were transferred 
to a cell culture system as in [6,7]. In brief, cells were 
harvested from the ascites fluid, cultured without 
shaking until they became adapted and then cultur- 
ed in suspension in Eagle’s basal medium supple- 
mented with 10% (v/v) foetal bovine serum under 
COz/air (1: 19) at 37°C. Cells were cloned in a 
microtitration tray. A cloned cell line, 2-E-6 cells, 
were adapted to grow in suspension with a gyratory 
shaker (model G-24, New Brunswick Scientific 
Co.). Their generation time was 13- 14. Cells in the 
exponentially growing phase were treated with 
1 mM sodium n-butyrate for 40 h to induce cyclo- 
oxygenase activity [7], since the cells had lipoxy- 
genase but little cyclooxygenase activity. Cell 
numbers were counted in a Coulter Counter (Model 
G, Coulter Electronics Inc., Hialeah FL). 
2. MATERIALS AND METHODS 
2.3. Assay of _5-lipoxygenase activity 
2.1. Materials 
The sources of the reagents used in these experi- 
ments were as follows: [ l-14C]arachidonic acid 
(spec. act. 55.5 Ci/mol), Radiochemical Centre 
(Amersham); foetal bovine serum (mycoplasma- 
and virus-free), Grand Island Biochemical Co. 
(NY); sodium n-butyrate, Wako Chemical Co. 
n-Butyrate treated cells were harvested by cen- 
trifugation at 200 x g for 5 min, and washed once 
with phosphate-buffered saline (Ca2+- and 
Mg2+ -free) (pH 7.4). The washed cells were sus- 
pended at 1 X 10’ cells/ml in incubation buffer 
consisting of 50 mM phosphate buffer (pH 7.4) 
1 mM EDTA, 0.1% gelatin and 10M5 M indo- 
methacin and sonicated 5 times for 4 s periods in a 
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Branson Sonifier (Model W-185; Ultrasonic, 
Plainview NY) at a setting of 3. The cell homo- 
genate was centrifuged at 10 000 x g for 10 min, 
and the resulting supernatant fraction was used for 
assay of lipoxygenase activity. Under the standard 
assay condition (1 .O ml), the supernatant fraction 
(0.9 ml) was incubated with 0.2 $i [14C]arachid- 
onic acid and 0.8 mM CaCl2 at 37°C for 5 min with 
shaking in an open tube. The reaction was termin- 
ated by adjusting the mixture to pH 3.0 with HCl. 
The synthesized HETEs were extracted with 8 vol. 
ethyl acetate, and the extract was condensed and 
subjected to thin-layer chromatography in solvent 
D, consisting of petroleum ether/diethyl ether/ 
acetic acid (50/50/l) as in [8]. 
Labeled HETEs separated on the plates were 
scanned with a Berthold Dtinnschicht Scanner II. 
Radioactive zones were scraped off the plate for 
measurement of radioactivity by a liquid scintilla- 
tion spectrometer. The activity of 5-lipoxygenase of 
the cells is expressed as the sum radioactivity of 
5-HETE and 5,12-diHETE, i.e., 14C-labeled 
HETEs/homogenate of 10’ cells. 
2.4. Assay ofprostaglandin synthetase activity 
The 10000 X g supernatant fraction from the 
above cell homogenate was used for assay of pros- 
taglandin synthetase activity. The supernatant 
fraction (0.9 ml) was incubated with 0.2 PCi [‘4C]- 
arachidonic acid at 37°C for 7 min with shaking in 
an open tube. In this assay condition, HETE was 
not synthesized (not shown). The reaction was ter- 
minated by adjusting the mixture to pH 3.0 with 
HCl. The prostaglandin synthesized were extracted 
with 8 vol. ethyl acetate, condensed and subjected 
to thin-layer chromatography with the upper phase 
of solvent C, consisting of ethyl acetate/2,2,4_tri- 
methylpentane/acetic acid/water (11/5/2/ 10, by 
vol.) as in 161. Labeled prostaglandins separated on 
the plates were scanned and the radioactive zones 
were each scraped off the plate for measurement of 
radioactivity. The prostaglandin synthetase activity 
of the cells is expressed as the sum radioactivit of 
each prostaglandin synthesized, i.e., cpm of &C_ 
labeled prostaglandins/homogenate of lo7 cells. 
2.5. Addition of inhibitors 
Inhibitors were dissolved in ethyl alcohol of rea- 
gent grade. These inhibitors could be dissolved in 
the solvent up to 2 mg/ml. Inhibitor solution (50 ~1) 
14 
of various concentrations or ethyl alcohol (50 ~1) for 
the control was transferred to the assay tube con- 
taining [‘4C]arachidonic acid in toluene. One drop 
of mixture of propylene glycol/ethyl alcohol (1:3) 
was added to the above tube. Organic solvent was 
evaporated completely under N2 gas stream before 
addition of enzyme and/or others to exclude the 
effect of the solvent. 
3. RESULTS AND DISCUSSION 
The cloned mastocytoma P-8 15, 2-E-6 cells used 
here can mainly sythesize 5-HETE and 5,12-di- 
HETE (LTB) with a slight production of 12-HETE 
from arachidonic acid under the culture conditions 
[9]. The cells have little cyclooxygenase activity un- 
less they are treated with 1 mM n-butyrate for 40 h 
[6,7,9]. n-Butyrate treatment can also cause an en- 
hancement of 5-lipoxygenase activity of the cells 
(submitted). Therefore, n-butyrate treatment is 
favourable to assay for both lipoxygenase and 
cyclooxygenase activities. Both enzymes were ob- 
tained from n-butyrate-treated cells and 10 000 X g 
supernatant fractions were prepared from cell 
homogenates. These assay conditions were fixed at 
linearly increasing activities of enzymes as in 
section 2. 
Effects of several derivatives of 5,6-methanoleu- 
kotriene A4 analogue on both 5-lipoxygenase and 
cyclooxygenase activities were studied. Various 
concentrations of the drugs were added separately 
to the enzyme mixtures and their effects on each 
enzyme were compared. Fig.1 shows a dose- 
response curve of 5,6-methanoleukotriene A4 me- 
thyl ester. The drug strongly inhibited the synthesis 
of both 5-HETE and 5,12-diHETE with inhibition 
of 12-HETE. The concentration of a half inhibition 
(IDso) for 5-lipoxygenase activity was 18 ,nM. On 
the other hand, the drug did not inhibit the synthe- 
sis of prostaglandins at all up to 150 PM, but slightly 
inhibited it at 300 PM. These results show that 
5,6-methanoleukotriene A4 methyl ester selectively 
inhibited one of the two main metabolic pathways 
of arachidonic acid, i.e., leukotriene and prosta- 
glandin synthesis. The effects of other 5,6-metha- 
noleukotriene A4 analogues on both enzymes are 
summarized in table 1. All these 5,6-methanoleu- 
kotriene A4 analogues tested showed selective inhi- 
bition for 5-lipoxygenase activity, although the 
relative potency was different. 5,6-Methanoleuko- 
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Table 1 
Inhibition of 5-lipoxygenase and cyclooxygenase activity by 5,6-methanoleukotriene A4 
derivatives 
5,6-Methanoleukotriene A4 derivatives 5-Lipoxygenase Cyclooxygenase 
KCN-TEI-6090 COOH 
KCN-TB I-6 
COOH 
127 
KCN-TEI-6173 
COOCH3 
\’ ’ 
KCN-TEI-6171 ~COOCH~ 
31 
44 
18 
30 
186 
'1136 
590 
l *1219 
KCN-TEI-6172 pCOOCH3 6 484 
ETYA [lOI (5,8,11-eicosatriynoic acid) 50 8 
BW 755C[ll] (3-amino-l-(m-tri-fluoromethyl)- ***7 3 
phenyl-2-pyrazoline 
l : no inhibition until 157 PM 
**: inhibited less than 15 per cent at 300 PM 
l **: result on 12-lipoxygenase 
15 
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Fig.1. Effect of 5,6-methanoleukotriene A4 on 5-lipoxy- 
genase and cyclooxygenase activity. Supernatant fraction 
(10 000 x g) obtained from cloned mastocytoma P-8 15, 
2-E-6 cells treated with n-butyrate was used for assay of 
5-lipoxygenase and cyclooxygenase activity as described 
in the text. Various concentration of 5,6-methanoleuko- 
triene methyl ester (KCN-TEI-6173 in table 1) was ad- 
ded to the assay. (a) HETE syntheses (O-O); 5-lipoxy- 
genase activity (5-HETE and 5,12-diHETE synthesized) 
(o-o); 5-HETE (n-0); 12-HETE. (b) Prostaglandin 
syntheses. 
triene A4 was much more selective than ETYA 
(5,8,1 I-eicosatriynoic acid) and BW 755C (3-amino- 
I-(m-trifluoromethyl)-phenyl-2-pyrazoline), which 
are well-known as lipoxygenase inhibitors. 
15-HETE, which has been reported to be a selective 
inhibitor of 5-lipoxygenase IS], was not effective as 
reported in this assay system. 
We still do not know the inhibitory mechanism of 
5,6-methanoleukotriene A4 but the analogues may 
act as antagonists to natural LTA4. The inhibitory 
effects of these drugs on inflammation in vivo are 
under investigation. 
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